Vicp.Si
VICP.SI operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
Business. VICP.SI operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
VICP.SI operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
The company's capital structure shows a debt-to-equity ratio of 0.58, indicating a moderate level of leverage. However, its liquidity position is assessed as medium, with a current ratio of 1.46, suggesting that the company has sufficient short-term assets to cover its short-term liabilities, but not with a large margin of safety. The company's cash and equivalents amount to SGD 4.714 million, which is significantly lower than its long-term debt of SGD 41.112 million, resulting in a negative net cash position.
In terms of profitability, the company reported a net loss of SGD 2.357 million, with a return on equity of -3.3% and a return on assets of -1.71%. These figures are below the industry median for profitability metrics, indicating that the company is underperforming relative to its peers in terms of generating returns for shareholders and utilizing its assets efficiently.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risks if demand in its primary market or product line declines.
The company's growth trajectory is uncertain, as the available data does not provide forward-looking revenue projections or historical growth rates. The negative net income and the absence of positive free cash flow suggest that the company is not currently generating sufficient cash to fund its operations and capital expenditures without external financing.
The company's risk assessment indicates a low potential for dilution, with no significant dilution events reported in the available data. However, the company's liquidity risk is assessed as medium, primarily due to its negative net cash position and the need to service its long-term debt.
Recent events, including filings and transcripts, are not detailed in the available data, making it difficult to assess the company's recent performance and strategic direction. The company's financial statements do not provide information on recent management discussions or significant business developments.
- The company has a moderate level of leverage with a debt-to-equity ratio of 0.58.
- The company is currently unprofitable, with a net loss and negative returns on equity and assets.
- The company's liquidity position is medium, with a current ratio of 1.46 and a negative net cash position.
- The company's growth trajectory is unclear, with no forward-looking revenue projections provided.
- The company has a low potential for dilution, but its liquidity risk is assessed as medium.
- margin_outlook_rationale: The company's margin outlook is negative due to its current net loss and negative returns on equity and assets.
- rd_outlook_rationale: No specific information is available to assess the company's research and development outlook.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- VICP.SI Market data — financials · 2026-05-29
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Shareholders' equity (YoY) (2023-12-31 vs 2022-12-31): -102.9%Derived (calculated)
- Operating cash flow (YoY) (2023-12-31 vs 2022-12-31): -75.3%Derived (calculated)
- Operating income (YoY) (2023-12-31 vs 2022-12-31): -6.3%Derived (calculated)
- Total assets (YoY) (2023-12-31 vs 2022-12-31): -44.9%Derived (calculated)
- R&D expense (YoY) (2023-12-31 vs 2022-12-31): 16.6%Derived (calculated)
- EPS (diluted) (YoY) (2023-12-31 vs 2022-12-31): 0.0%Derived (calculated)
- EPS (basic) (YoY) (2023-12-31 vs 2022-12-31): 0.0%Derived (calculated)
- Return on equity (FY 2023-12-31): 61.3%Derived (calculated)
- Return on assets (FY 2023-12-31): -2,980.9%Derived (calculated)
- Current ratio (FY 2023-12-31): 0.02xDerived (calculated)
- Cash & equivalents (YoY) (2023-12-31 vs 2022-12-31): -33.2%Derived (calculated)
- Net income (YoY) (2023-12-31 vs 2022-12-31): -20.0%Derived (calculated)
- Pre-tax income (annual): USD -1.18MSEC XBRL filing
- R&D expense (annual): USD 15.27KSEC XBRL filing
- Cash & equivalents (annual): USD 9.42KSEC XBRL filing
- Current assets (annual): USD 39.66KSEC XBRL filing
- Operating cash flow (annual): USD -417.52KSEC XBRL filing
- Shares outstanding (annual): 32.07MSEC XBRL filing
- Net income (annual): USD -1.18MSEC XBRL filing
- Total assets (annual): USD 39.66KSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
- Operating income (annual): USD -1.05MSEC XBRL filing
- Total operating expenses (annual): USD 1.05MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing